Semaglutide Injectable Suppliers & Bulk Manufacturers
Available Forms: Injection(SQ)
Available Strengths: 0,25 mg - 2.4 mg per injection for weight management
Reference Brands: Wegovy(US & EU)
Category: Weight Loss drugs
Semaglutide injection is a once-weekly GLP-1 medicine for type 2 diabetes (Ozempic, 0.25 to 2 mg) and weight management (Wegovy, up to 2.4 mg). The semaglutide patent expired in India in March 2026 and Indian companies have launched generic versions; Canada, Brazil and China are following, while US and EU patents run for several more years. Patent status differs by country, so we confirm what can lawfully be supplied to your destination before quoting.
Manufacture or export Semaglutide Injectable? List it or send an offer →
Product Description:
Wegovy (semaglutide 2.4 mg) injection is approved in the US by the FDA and in the EU via EMA for chronic weight management. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures regional safety and manufacturing compliance. For dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports swift approval, safe administration, and global availability, helping patients worldwide achieve significant weight loss and improved metabolic health through high-quality, long-acting GLP-1 receptor agonist therapies.
Patent and generic status: generic semaglutide can legally be supplied in some markets but not yet in others. See our guide, Semaglutide patent expiry by country, before placing an order.
Semaglutide Injectable — third party manufacturing & bulk supply
Semaglutide Injectable is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Semaglutide Injectable is supplied as Injection(SQ) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Semaglutide Injectable listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Semaglutide Injectable →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Semaglutide is used to improve blood sugar control in adults with type 2 diabetes mellitus and to aid in chronic weight management for obese or overweight individuals with related health conditions. It helps lower blood glucose levels by stimulating insulin release and reducing appetite.
Semaglutide is a synthetic peptide analogue of human glucagon-like peptide-1 (GLP-1). It is produced through recombinant DNA technology in yeast and modified to resist enzymatic degradation, allowing longer activity in the body.
The main trade names of Semaglutide are Ozempic, Wegovy, and Rybelsus.
Semaglutide is manufactured by Novo Nordisk A/S.
The generic name is Semaglutide.
Brand names include Ozempic (for type 2 diabetes), Wegovy (for weight management), and Rybelsus (oral form for diabetes).
Semaglutide is manufactured by Novo Nordisk in Denmark and also at its production facilities in the United States.
Ozempic (0.25–2 mg weekly) for type 2 diabetes and Wegovy (up to 2.4 mg weekly) for weight management; Rybelsus is the oral tablet.
Unused pens at 2–8 °C; after first use, at room temperature (up to 30 °C) or in the fridge for up to 6 weeks (Ozempic).
Indian generics can be supplied to markets where the semaglutide patent has expired or never existed; we check the destination's patent and registration status before quoting.
Related Products
Black Seed Oil Capsules And Tablets
Strength:
500 mg, 1000 mg
Form: Capsules and Tablets
Reference Brands: Now Foods, Source Naturals, Solgar(US)
View DetailsLiraglutide Injection
Strength:
3 mg/mL
Form: Injection
Reference Brands: Saxenda(US & EU), Victoza (India/USA)
View DetailsPhentermine/Topiramate Extended-Release Capsules
Strength:
3.75 mg/23 mg, 7.5 mg/46 mg, and 15 mg/92 mg
Form: Capsules
Reference Brands: Qsymia(US & EU)
View DetailsNaltrexone Hydrochloride + Bupropion Hydrochloride Er Tablets
Strength:
8 mg naltrexone hydrochloride / 90 mg bupropion hydrochloride
Form: ER tablets
Reference Brands: Contrave(US & EU)
View DetailsOrlistat Capsule
Strength:
120 mg; Alli(60 mg)
Form: Capsules
Reference Brands: Xenical(US & EU)
View DetailsSetmelanotide Injectable Solution
Strength:
4 mg/mL
Form: Injectable Solution
Reference Brands: Imcivree(Us & EU)
View DetailsMetreleptin Injectable Solution
Strength:
11.3 mg/vial
Form: Injectable Solution
Reference Brands: Myalept(US & EU)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit